Suspended
Clinical Efficacy of a Novel Delivery Supplement on Sleep Quality
What is being tested
Circadian Wellness sleep SL strip
Dietary Supplement
Who is being recruted
From 16 to 65 Years
+18 Eligibility Criteria
How is the trial designed
Other Study
Placebo-Controlled
Interventional
Study Start: August 2021
Summary
Principal SponsorTruDiagnostic
Study ContactSanjeev Goel, MDMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Study start date: August 30, 2021
Actual date on which the first participant was enrolled.This is a prospective randomized clinical study of 30 patients to evaluate a novel sleep supplement. This study will be evaluating the effectiveness of the supplement over a 2 month program. The study will assess the effects that the supplement has on a patient's sleep metrics and epigenetic age biomarkers.
Official TitleClinical Efficacy of a Novel Delivery Supplement on Sleep Quality
Principal SponsorTruDiagnostic
Study ContactSanjeev Goel, MDMore contacts
Last updated: January 28, 2026Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
30 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 16 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
3 inclusion criteria required to participate
Men and women of any ethnicity.
Age Range - 16 - 65
Patient must be able to comply with treatment plan and laboratory tests
15 exclusion criteria prevent from participating
Neoplastic cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision
No immune system issues or immunodeficiency disease
No history of viral illness which could be reactivated by immune downregulation
Presence of clinically significant acute or unstable cardiovascular and cerebrovascular (stroke)
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboParticipants in the control group will have no intervention and no change in their usual daily routine or supplements. They will be asked to not take any sleep aid supplement during the study period.
Group II
ExperimentalCircadian Wellness sleep SL strip nightly for 30 days.
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has no location dataSave this study to your profile to know when the location data is available.
SuspendedNo study centers